GSK plc (GSK) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-03 (expected, time not announced). EPS estimate 0.28, revenue estimate 8.84B.
Over the last 12 reports the stock moved 4.7% on average (either way), rising 7 times and falling 5. EPS beat estimates 12 of 12 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-28 | 0.55 | 0.50 | +8.5% | 8.89B | 8.86B | -5.7% |
| Q2 FY2026 | 2026-07-29 | 0.51 | 0.46 | +8.7% | 8.41B | 8.25B | -4.4% |
| Q1 FY2026 | 2026-04-29 | 0.45 | 0.42 | +7.8% | 7.43B | 7.63B | -4.9% |
| Q4 FY2025 | 2026-02-04 | 0.25 | 0.24 | +7.1% | 8.53B | 8.46B | +12.1% |
| Q3 FY2025 | 2025-10-29 | 0.56 | 0.48 | +17.2% | 8.74B | 8.23B | +8.5% |
| Q2 FY2025 | 2025-07-30 | 0.48 | 0.45 | +7.3% | 8.25B | 7.78B | +1.5% |
| Q1 FY2025 | 2025-04-30 | 0.44 | 0.39 | +12.3% | 7.31B | 7.39B | +2.2% |
| Q4 FY2024 | 2025-02-04 | 0.23 | 0.20 | +17.0% | 8.20B | 7.77B | +6.2% |